Lim Jonathan E

Lim Jonathan E is listed in filings as Director at Boundless Bio, Inc.. This profile follows SEC Form 4 activity through Jun 15, 2026, including 6 public disclosures. Recent filings connect the profile to Boundless Bio, Inc. (BOLD), Maze Therapeutics, Inc. (MAZE), and Erasca, Inc. (ERAS). The current snapshot covers public activity from Jun 21, 2024 to Jun 15, 2026. Reported amounts are shown as $67.2K to $1.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.